About the Authors

Toshiko Mori

Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

mori@edogawa.or.jp (TM); ito@edogawa.or.jp (HI)

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan

Hiroyuki Ito

Roles Conceptualization, Data curation, Investigation, Visualization, Writing – review & editing

mori@edogawa.or.jp (TM); ito@edogawa.or.jp (HI)

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan

Taiki Kozasa

Roles Formal analysis, Writing – review & editing

Affiliation Clinical Test Management Division, PreMedica Inc., Tokyo, Japan

Chizuko Yukawa

Roles Data curation, Writing – review & editing

Affiliation Laboratory Department, Edogawa Hospital, Tokyo, Japan

Suzuko Matsumoto

Roles Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan

Hideyuki Inoue

Roles Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan

Shinichi Antoku

Roles Writing – review & editing

Affiliation Department of Diabetes, Metabolism and Kidney Disease, Edogawa Hospital, Tokyo, Japan

Competing Interests

Hiroyuki Ito received lecture fees from Novo Nordisk Pharma Ltd., Eli Lilly Japan KK, Sanofi KK, Astellas Pharma, Kowa Company, Ltd., Taisho Pharmaceutical Co., Ltd., Sumitomo Pharma Co., Ltd., Boehringer Ingelheim, Daiichi Sankyo Company, Novartis Pharma KK, Takeda Pharmaceutical Company Ltd., MSD KK, Terumo Corporation, Mochida Pharmaceuticals, Teijin Pharma, Kissei Pharmaceuticals, Mitsubishi Tanabe Pharma Corporation, Sanwa Kagaku Kenkyusho, AstraZeneca KK, Kyowa Kirin Co. Ltd., Otsuka Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., EA Pharma Co., Ltd., Ono Pharmaceutical Co., Ltd., and Viatris Inc., and received consulting fees from Becton, Dickinson and Company. Suzuko Matsumoto received lecture fees from Eli Lilly Japan KK, Novo Nordisk Pharma Ltd., Astellas Pharma, Kyowa Kirin Co., Ltd., and AstraZeneca KK. Hideyuki Inoue received lecture fees from Novartis Pharma KK, AstraZeneca KK, and Mochida Pharmaceuticals. Shinichi Antoku received lecture fees from Kyowa Kirin Co., Ltd., Sanofi KK, Taisho Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Novo Nordisk Pharma Ltd., Novartis Pharma KK, AstraZeneca KK, and Otsuka Pharmaceutical Co., Ltd. Toshiko Mori received lecture fees from Novartis Pharma KK. Taiki Kozasa and Chizuko Yukawa has no conflict of interest.